Understanding an Increasingly Complex Treatment Landscape in Urothelial Carcinoma: Guidance for Frontline Oncology Practitioners

A comprehensive educational program to equip oncology nurses nurse practitioners physician assistants and pharmacists with up-to-date information to incorporate new and emerging therapies into clinical practice.

Share

Program Content

Activities

New Treatment Options For UC
Call To Action: Integrating New Treatment Options for Urothelial Cancer Into Clinical Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2020

Expires: September 14, 2021

Activities

UC Toxicity Resource
Clinical Resource: Toxicity Management Guide for Erdafitinib and Enfortumab Vedotin in Treatment of Urothelial Carcinoma
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2020

Expires: November 04, 2021

Patient Safety Guide
Patient Safety Guide for Erdafitinib and Enfortumab Vedotin: What to Look for and What to Report to Your Healthcare Team
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 06, 2021

Expires: January 05, 2022

Treatment Options for UC
Treatment Options for Patients With Advanced or Metastatic Urothelial Carcinoma: At-a-Glance Clinical Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 07, 2021

Expires: January 06, 2022

Activities

UC Guidance: Slides
Understanding an Increasingly Complex Treatment Landscape in Urothelial Carcinoma: Guidance for Frontline Oncology Practitioners
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2021

Expires: January 10, 2022

Activities

UC Therapy: Pharmacy Perspective
Therapeutic Strategies for Pretreated Metastatic UC: A Pharmacy Perspective
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2020

Expires: November 12, 2021

Understanding Enfortumab Vedotin
Understanding the Therapeutic Antibody–Drug Conjugate Enfortumab Vedotin
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2020

Expires: December 15, 2021

Understanding Erdafitinib
Understanding the FGFR-Targeted Therapy Erdafitinib
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Treating mUC: Nursing Perspective
Therapeutic Strategies for Pretreated Metastatic UC: A Nursing Perspective
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2020

Expires: November 29, 2021

Managing AEs: Enfortumab Vedotin
Managing AEs With Enfortumab Vedotin: A Patient Case Example
Case Challenge
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2020

Expires: December 21, 2021

Managing AEs: Erdafitinib
Managing AEs With Erdafitinib: A Patient Case Example
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

Expires: December 20, 2021

Faculty

cover img faculity

Susan Knight, PT, PCS

Physical Therapist
Los Angeles, California

cover img faculity

Susan Kralian, PhD

Editorial Contributor

cover img faculity

Kinjal Patel, PharmD, BCOP

Clinical Oncology Pharmacist
Department of Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Susan Roethke, CRNP, MSN, AOCN, ANP-BC

Nurse Practitioner
Department of Hematology/Oncology
Genitourinary Medical Oncology
Fox Chase Cancer Center
Temple Health
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Astellas Seattle Genetics

Janssen administered by Scientific Affairs